This inventor holds 1 USPTO granted patent. Top assignees: The State University of New York, University of Florida Research Foundation Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 2,046 
1 out of 3,058 
Years Active: 2025
Title: Agnieszka B Bialkowska: Innovator in Cancer Therapy
Introduction
Agnieszka B Bialkowska is a prominent inventor based in East Setauket, NY (US). She has made significant contributions to the field of cancer therapy through her innovative research and development of small molecules aimed at reducing the expression of key transcription factors involved in tumor growth.
Latest Patents
Agnieszka holds 1 patent for her work titled "Small molecules for cancer therapy that reduce the expression of transcription factors KLF5 and EGR-1." This patent describes compounds that are effective in reducing the expression levels of KLF5 or EGR1 in living cells, providing a potential treatment for tumors and colorectal cancer in human patients.
Career Highlights
Throughout her career, Agnieszka has worked with esteemed institutions such as the University of Florida Research Foundation and the State University of New York. Her research has focused on developing therapeutic strategies that target critical pathways in cancer biology.
Collaborations
Agnieszka has collaborated with notable colleagues, including Thomas D Bannister and Chao Wang, to advance her research and contribute to the scientific community.
Conclusion
Agnieszka B Bialkowska's innovative work in cancer therapy exemplifies her commitment to improving patient outcomes through scientific research. Her contributions continue to pave the way for new therapeutic approaches in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile